glp-1 micro dosing Microdosing GLP-1: A Next-Generation Approach to Metabolic and Longevity Medicine: Shamsah Amersi, MD: OB-GYNs People are 'microdosing' weight-loss drugs.

reported lower serum calcium and ferritin, lower HDL cholesterol, and higher LDL cholesterol levels in patients with PG vs controls.20 Premature graying has been linked to early cardiovascular disease, and dyslipidemia may serve as a connecting factor.5 Furthermore, lower vitamin D levels have been reported in patients with PG, although without statistically significant associations.20,27 Regarding copper, lower levels have been observed in PG patients vs controls, but without statistical significance.28,29 Comorbidities Several studies have reported a higher prevalence of atopic diathesis in patients with PG.20,26,30 Das et al

The down-regulation of lactoferrin expression induced by cigarette smoke can induce ferroptosis in COPD

In a highly litigious atmosphere, with several major compounding players opting not to test the limits of whats legally permissible, there will indeed be a significant subset of patients who struggle to find accessible, affordable meds

Activation of neurokinin-1 receptor by substance P inhibits melanogenesis in B16-F10 melanoma cells

Bu, T., Sun, Z., Pan, Y., et al